Generation Bio Co (GBIO) Stock
GBIO is no longer traded. Generation Bio Co was delisted from the Nasdaq in February 2026.
Prices on this page are historical; the last trade was February 6, 2026 at $5.34.
Generation Bio Co stock price history
GBIO final trading statistics
- Final close
- $5.34
- Final trading day
- Feb 6, 2026
- Market cap at delisting
- $35.98M
- Shares outstanding
- 6.74M
- Final 52-week range
- $0.30 – $6.95
- Avg. volume (final 3 mo.)
- 85,138
- All-time high (split-adj.)
- $516.10 · Dec 2020
- All-time low (split-adj.)
- $3.00 · Jun 2025
- Return since IPO
- -97.8%
- Beta
- 2.01
- Book value / share
- $7.51
- Price / book
- 0.71
Generation Bio Co annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $19.89M | -$131.7M | -$1.93 |
| FY2023 | $5.90M | -$126.6M | -$1.96 |
| FY2022 | $880.0K | -$132.1M | -$2.35 |
| FY2021 | $0.00 | -$114.7M | -$2.11 |
| FY2020 | $0.00 | -$76.5M | -$3.29 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Generation Bio Co
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Generation Bio Co stock FAQ
What happened to Generation Bio Co stock?
Generation Bio Co stock was delisted from the Nasdaq. Its final close was $5.34 on February 6, 2026.
Is GBIO stock still trading?
No. GBIO was delisted from the Nasdaq in February 2026 and no longer trades on a U.S. exchange.
What was the last price of GBIO stock?
GBIO closed at $5.34 on its final trading day, February 6, 2026, for a market value of about $35.98M.
What were Generation Bio Co's revenue and earnings in its last full fiscal year?
Generation Bio Co reported revenue of $19.89M and net income of -$131.7M in fiscal 2024, its last full year as a public company.
When did Generation Bio Co go public?
Generation Bio Co stock began trading on June 12, 2020.